NCT05024045 2026-03-03Study of Oral LOXO-338 in Patients With Advanced Blood CancersEli Lilly and CompanyPhase 1 Active not recruiting316 enrolled
NCT07426484 2026-02-23Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyDana-Farber Cancer InstitutePhase 4 Not yet recruiting80 enrolled